Biomemory launches DNA Shield for secure synthetic DNA data storage
Biomemory has unveiled DNA Shield, a service that stores critical digital assets in synthetic DNA with full commercial availability expected in 2027.
Acquisition enables new storage service
The company launched this offering following its acquisition of Boston-based Catalog Technologies in March 2026. This move allows Biomemory to provide organizations with a repository for data that remains offline and airgapped.
Service targets cold data assets
The system protects passwords, biometrics, and financial records from cyber criminals and artificial intelligence threats. These stored items function as long-term physical molecules that do not require power to maintain integrity.
Pilot program opens now
Biomemory has opened pilot slots for the technology ahead of the full service launch scheduled for 2027. The company foresees challenges to the resilience of these critical digital assets known as cold data.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.